Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
364 studies found for:    Osteosarcoma
Show Display Options
Rank Status Study
21 Completed
Has Results
Chemotherapy for Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Pemetrexed
22 Active, not recruiting A Placebo-Controlled Study of Saracatinib (AZD0530) in Patients With Recurrent Osteosarcoma Localized to the Lung
Condition: Osteosarcoma
Interventions: Drug: Saracatinib;   Drug: Placebo
23 Completed Genetic Biomarkers in Tissue Samples From Patients With Osteosarcoma
Condition: Osteosarcoma
Intervention: Other: laboratory biomarker analysis
24 Completed Mifamurtide (L-MTP-PE) for High-Risk Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide (L-MTP-PE)
25 Recruiting Phase II Trial for the Treatment of Relapsed Osteosarcoma
Condition: OSTEOSARCOMA
Interventions: Drug: Gemcitabine and Docetaxel;   Drug: Ifosfamide
26 Active, not recruiting Surveillance Study of Patients With Newly Diagnosed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Mifamurtide
27 Completed Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain Reaction
Condition: Osteosarcoma
Intervention: Other: Blood draw
28 Recruiting Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma
Condition: Osteosarcoma
Interventions: Drug: Lithium Carbonate;   Drug: Placebo
29 Completed A Retrospective Non-intervention Study to Characterize FOlate Rescue Treatment in Osteosarcoma Patients Treated With HDMTX
Condition: Osteosarcoma
Intervention: Drug: Methotrexate
30 Active, not recruiting Adjuvant High-Dose Thiotepa and Stem Cell Rescue Associated With Conventional Chemotherapy in Relapsed Osteosarcoma
Condition: Osteosarcoma
Intervention: Drug: Thiotepa
31 Recruiting Investigation of [6R] 5,10-methylenetetrahydrofolate as Rescue Therapy for Osteosarcoma Patients Treated With HDMTX.
Condition: Osteosarcoma
Interventions: Drug: Leucovorin;   Drug: [6R] 5,10-methylenetetrahydrofolate
32 Completed Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma
Conditions: Metastatic Osteosarcoma;   Relapsed Osteosarcoma
Interventions: Drug: Sorafenib;   Drug: Everolimus
33 Completed Eribulin Mesylate in Treating Patients With Recurrent or Refractory Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Drug: Eribulin Mesylate;   Other: Pharmacological Study
34 Recruiting Study of Pazopanib in the Treatment of Osteosarcoma Metastatic to the Lung
Conditions: Osteosarcoma;   Metastatic Osteosarcoma
Intervention: Drug: pazopanib
35 Completed Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic Osteosarcoma
Condition: Metastatic Osteosarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: cisplatin;   Drug: methotrexate;   Drug: leucovorin calcium;   Biological: filgrastim;   Procedure: therapeutic conventional surgery;   Radiation: radiation therapy;   Drug: etoposide;   Drug: ifosfamide;   Biological: trastuzumab;   Other: laboratory biomarker analysis
36 Completed Genetic Characterisation of High-grade Paediatric Osteosarcomas
Condition: Paediatric Osteosarcomas
Intervention:
37 Recruiting Glembatumumab Vedotin in Treating Patients With Recurrent or Refractory Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Drug: Glembatumumab Vedotin;   Other: Laboratory Biomarker Analysis;   Other: Pharmacological Study
38 Terminated Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:
Conditions: Osteosarcoma;   Paget's Disease
Intervention:
39 Recruiting Humanized Monoclonal Antibody 3F8 (Hu3F8) With Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) in the Treatment of Recurrent Osteosarcoma
Condition: Recurrent Osteosarcoma
Interventions: Biological: humanized anti-GD2 antibody;   Drug: GM-CSF
40 Active, not recruiting Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma
Conditions: Localized Osteosarcoma;   Metastatic Osteosarcoma
Interventions: Drug: doxorubicin hydrochloride;   Drug: cisplatin;   Drug: methotrexate;   Procedure: therapeutic conventional surgery;   Biological: peginterferon alfa-2b;   Drug: ifosfamide;   Drug: etoposide;   Procedure: quality-of-life assessment;   Other: questionnaire administration

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.